Research Article
Overexpression of GSE1 Related to Trastuzumab Resistance in Gastric Cancer Cells
Table 1
Correlation between GSE1 levels and pathological features in HER2-positive gastric cancer patients.
| | | GSE1 levels ( (%)) | | Parameter | | Low | High |
| Age (years) | | | | | ≤60 | 15 | 6 (40.0) | 9 (60.0) | | >60 | 25 | 10 (40.0) | 15 (60.0) | 1.000 | Tumor size (cm) | | | | | ≤5 | 23 | 10 (43.5) | 13 (56.5) | | >5 | 17 | 6 (35.3) | 11 (64.7) | 0.601 | Lymph node metastasis | | | | | No | 18 | 11 (61.1) | 7 (38.9) | | Yes | 22 | 5 (22.7) | 17 (77.3) | 0.014 | Grade | | | | | I-II | 24 | 9 (37.5) | 15 (62.5) | | III | 16 | 7 (43.8) | 9 (56.2) | 0.693 | Stage | | | | | I-II | 17 | 10 (58.8) | 7 (41.2) | | III-IV | 23 | 6 (26.1) | 17 (73.9) | 0.037 |
|
|